Cargando…
Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism
Background: Increased knowledge of the pharmacokinetic characteristics of orally administered levothyroxine (L-T(4)) has improved individualization of dosing regimens. However, up to 40–45% of patients, depending on the leading cause of hypothyroidism, are still over- or, more often, undertreated. U...
Autores principales: | Trimboli, Pierpaolo, Mouly, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224574/ https://www.ncbi.nlm.nih.gov/pubmed/35743549 http://dx.doi.org/10.3390/jcm11123479 |
Ejemplares similares
-
Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018) -
SUN-590 Failure to Control Severe Hypothyroidism with L-Thyroxine Tablets Corrected by Switching to Oral Soft Gel Formulation
por: Solhjoo, Mahdis, et al.
Publicado: (2019) -
PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022) -
Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients
por: Benvenga, Salvatore
Publicado: (2019) -
FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)